Rovi (ROVI -37.2%) is Nasdaq's biggest loser after Q3 earnings plunged, expenses soared and expected revenue growth was lowered. Canaccord's continued faith aside, at least three analysts weigh in with downgrades and huge price target cuts. John Vinh of Collins Stewart sees no near-term catalysts, as "many of the growth drivers we had been anticipating have been pushed to late 2012."
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 8:53AM)
Pre-Market Most Active for Feb 27, 2015 : ROVI, TOT, JCP, BLMN, BAC, HMC, PBR, FCAU, TVIX, AAPL, CLNE, HZNPat Nasdaq.com (Fri, 8:39AM)
at Nasdaq.com (Jan 23, 2015)
at Nasdaq.com (Jan 9, 2015)
at Benzinga.com (Dec 30, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs